AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

RepliCel Life Sciences Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 13:39 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0.04
Market Cap
7.36K
AVG Volume
28
Trailing/Forward PE
-9.38/-
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
0200K400K600K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
26 Q2530.58K
26 Q1442.11K
25 Q4414.89K
25 Q3149.88K
25 Q2238.31K
25 Q1326.75K
24 Q4353.74K
24 Q3353.74K
24 Q2353.74K
24 Q1353.74K
Net Income (CAD) · TTM
-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
26 Q27.73M
26 Q17.77M
25 Q4-401.63K
25 Q3-7.71M
25 Q2-7.9M
25 Q1-8.06M
24 Q4-90.13K
24 Q31.37M
24 Q2769.23K
24 Q1399.02K
Operating Income (CAD) · TTM
-1M-500K0500K1M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
26 Q2545.45K
26 Q1460.23K
25 Q4237.84K
25 Q3-314.9K
25 Q2-386.99K
25 Q1-422.21K
24 Q4-404.44K
24 Q3-574.45K
24 Q2-819.79K
24 Q1-954.36K
EBITDA (CAD) · TTM
-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
26 Q2536.84K
26 Q1460.36K
25 Q4238.97K
25 Q3-260.66K
25 Q2-332.61K
25 Q1-376.45K
24 Q4-359.55K
24 Q3-573.04K
24 Q2-1.31M
24 Q1-1.8M
Cash Flows (CAD) · TTM
-600K-400K-200K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
26 Q2-135.61K
26 Q1-179.1K
25 Q4-296.08K
25 Q3-369.88K
25 Q2-397.9K
25 Q1-522.06K
24 Q4-530.86K
24 Q3-88.22K
24 Q2-235.39K
24 Q1-452.93K
EPS (CAD) · TTM
-0.2-0.100.10.224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
26 Q20.11
26 Q10.11
25 Q4-0.01
25 Q3-0.11
25 Q2-0.12
25 Q1-0.12
24 Q4-0
24 Q30.02
24 Q20.01
24 Q10.01
Expenses (CAD) · TTM
-500K0500K1M1.5MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
26 Q2-14.39K
26 Q1-17.64K
25 Q4115.6K
25 Q3403.26K
25 Q2563.78K
25 Q1642.67K
24 Q4713.69K
24 Q3882.58K
24 Q21.13M
24 Q11.31M
Shares Outstanding (CAD) · TTM
-400K-200K0200K400KBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
26 Q20
26 Q10
25 Q40
25 Q3-31.94K
25 Q2-31.94K
25 Q1-31.94K
24 Q4-31.94K
24 Q3363.84K
24 Q2129.24K
24 Q1156.76K
Employee Count
024682013201420152016201720182019202020212022
REPCF Employee Count by quarter
PeriodEmployee Count
20222
20211
20202
20192
20182
20172
20162
20156
20147
20135
PE Ratio
02.557.510med 0.13Jul 24Sep 24Nov 24Dec 24Feb 25Jul 26Sep 26
REPCF PE Ratio by quarter
PeriodPE Ratio
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Mar 250.13
Mar 250.13
Mar 250.13
Mar 250.13
Feb 250.13
Feb 250.13
Feb 250.12
Feb 250.12
Jan 250.12
Jan 250.06
Jan 250.65
Jan 250.65
Jan 250.65
Dec 240.12
Dec 240.57
Dec 240.23
Dec 240.23
Nov 240.23
Nov 240.22
Nov 240.02
Nov 240.06
Nov 240.06
Oct 240.06
Oct 240.47
Oct 240.47
Oct 240.47
Sep 240.89
Sep 240.9
Sep 240.9
Sep 240.9
Aug 240.89
Aug 240.89
Aug 240.91
Aug 240.91
Aug 240.92
Jul 240.92
Jul 249.05
Jul 248.99
Jul 249
Free Cash Flow Yield
-40000%-30000%-20000%-10000%0%med -1820.21%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
REPCF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1844.72%
Sep 26-1849.69%
Aug 26-1840.41%
Aug 26-1858.89%
Aug 26-1844.24%
Aug 26-1835.86%
Jul 26-1825.91%
Jul 26-1815.53%
Jul 26-1824.89%
Jul 26-1808.01%
Jul 26-1804.13%
Jun 26-2981.02%
Jun 26-2991.74%
Jun 26-3023.69%
Jun 26-3034.54%
May 26-3067.66%
May 26-3061.47%
May 26-3077.13%
May 26-3092.95%
May 26-3113.17%
Apr 26-3095.01%
Apr 26-3089.69%
Apr 26-3056.16%
Apr 26-30388.34%
Mar 26-3619.24%
Mar 26-3664.54%
Mar 26-3664.06%
Mar 26-3707.57%
Feb 26-3686.25%
Feb 26-3676.66%
Feb 26-3692.75%
Feb 26-3677.54%
Jan 26-3692.21%
Jan 26-3670.37%
Jan 26-3613.18%
Jan 26-3614.06%
Jan 26-3662.14%
Dec 25-4157.87%
Dec 25-4120.11%
Dec 25-4128.04%
Dec 25-4114.68%
Nov 25-4068.76%
Nov 25-4032.22%
Nov 25-4054.8%
Nov 25-4047.15%
Oct 25-4059.66%
Oct 25-4062.19%
Oct 25-4055.15%
Oct 25-4061.29%
Oct 25-4076.38%
Sep 25-5350.67%
Sep 25-5415.36%
Sep 25-5387.19%
Sep 25-269.75%
Aug 25-271.43%
Aug 25-269.81%
Aug 25-269.94%
Aug 25-271.11%
Aug 25-270.47%
Jul 25-272.24%
Jul 25-271.82%
Jul 25-272.49%
Jul 25-274.55%
Jun 25-299.9%
Jun 25-298.71%
Jun 25-302.09%
Jun 25-299.66%
May 25-298.64%
May 25-298.81%
May 25-293.72%
May 25-294.46%
May 25-296.98%
Apr 25-296.21%
Apr 25-296.54%
Apr 25-295.89%
Apr 25-288.34%
Mar 25-50.16%
Mar 25-50.03%
Mar 25-49.96%
Mar 25-49.99%
Feb 25-49.65%
Feb 25-50.5%
Feb 25-53.29%
Feb 25-52.9%
Jan 25-52.03%
Jan 25-100.13%
Jan 25-9.92%
Jan 25-9.96%
Jan 25-9.94%
Dec 24-265.9%
Dec 24-53.33%
Dec 24-134.65%
Dec 24-135.38%
Nov 24-130.33%
Nov 24-137.12%
Nov 24-1295.5%
Nov 24-475.13%
Nov 24-473.74%
Oct 24-475.65%
Oct 24-64.82%
Price to Sales
0123med 0.07Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
REPCF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.02
Sep 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jun 260.02
Jun 260.02
Jun 260.02
Jun 260.02
May 260.02
May 260.02
May 260.02
May 260.02
May 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Apr 260
Mar 260.07
Mar 260.07
Mar 260.07
Mar 260.07
Feb 260.07
Feb 260.07
Feb 260.07
Feb 260.07
Jan 260.07
Jan 260.07
Jan 260.07
Jan 260.07
Jan 260.07
Dec 250.04
Dec 250.04
Dec 250.04
Dec 250.04
Nov 250.04
Nov 250.04
Nov 250.04
Nov 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Sep 250.03
Sep 250.03
Sep 250.03
Sep 250.59
Aug 250.59
Aug 250.59
Aug 250.59
Aug 250.59
Aug 250.59
Jul 250.59
Jul 250.59
Jul 250.59
Jul 250.58
Jun 250.5
Jun 250.5
Jun 250.5
Jun 250.5
May 250.5
May 250.5
May 250.51
May 250.51
May 250.51
Apr 250.51
Apr 250.51
Apr 250.51
Apr 250.52
Mar 250.5
Mar 250.5
Mar 250.5
Mar 250.5
Feb 250.5
Feb 250.49
Feb 250.47
Feb 250.47
Jan 250.48
Jan 250.25
Jan 252.51
Jan 252.5
Jan 252.51
Dec 240.25
Dec 241.25
Dec 240.49
Dec 240.49
Nov 240.51
Nov 240.49
Nov 240.05
Nov 240.14
Nov 240.14
Oct 240.14
Oct 241.03
EV/EBITDA
22.533.544.5med 4.27Apr 26May 26Jun 26Jul 26Aug 26Sep 26
REPCF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 262.33
Sep 262.33
Aug 262.33
Aug 262.33
Aug 262.33
Aug 262.33
Jul 262.33
Jul 262.33
Jul 262.33
Jul 262.33
Jul 262.33
Jun 264.29
Jun 264.29
Jun 264.29
Jun 264.29
May 264.29
May 264.29
May 264.29
May 264.29
May 264.29
Apr 264.29
Apr 264.29
Apr 264.29
Apr 264.26
RepliCel Life Sciences Inc.
REPCF
Stockpicker

Video analysis: REPCF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.